Baker WL, White CM. Role of Prasugrel, a Novel P2Y12 Receptor Antagonist, in the Management of Acute Coronary Syndromes. American Journal of Cardiovascular Drugs Aug 1, 2009; 9 (4): 213-229. Link text
Wiviott, Stephen D.; Braunwald, Eugene; McCabe, Carolyn H.; Montalescot, Gilles; Ruzyllo, Witold; Gottlieb, Shmuel; Neumann, Franz-Joseph; Ardissino, Diego et al. (15 November 2007). “Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes”. New England Journal of Medicine357 (20): 2001–2015. doi:10.1056/NEJMoa0706482. PMID17982182.
Wiviott, Stephen D.; Braunwald, Eugene; McCabe, Carolyn H.; Montalescot, Gilles; Ruzyllo, Witold; Gottlieb, Shmuel; Neumann, Franz-Joseph; Ardissino, Diego et al. (15 November 2007). “Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes”. New England Journal of Medicine357 (20): 2001–2015. doi:10.1056/NEJMoa0706482. PMID17982182.
Chew, Derek P; Scott, Ian A; Cullen, Louise; French, John K; Briffa, Tom G; Tideman, Philip A; Woodruffe, Stephen; Kerr, Alistair et al. (August 2016). “National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand: Australian clinical guidelines for the management of acute coronary syndromes 2016”. Medical Journal of Australia205 (3): 128–133. doi:10.5694/mja16.00368. PMID27465769.
“Current oral antiplatelets: focus update on prasugrel”. Journal of the American Board of Family Medicine25 (3): 343–9. (2012). doi:10.3122/jabfm.2012.03.100270. PMID22570398.
“Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials”. Lancet374 (9694): 989–997. (September 2009). doi:10.1016/S0140-6736(09)61525-7. PMID19726078.
Wiviott SD, Braunwald E, McCabe CH et al. (2007). “Prasugrel versus clopidogrel in patients with acute coronary syndromes”. N Engl J Med357 (20): 2001–15. doi:10.1056/NEJMoa0706482.
Ruff, Christian T.; Giugliano, Robert P.; Antman, Elliott M.; Murphy, Sabina A.; Lotan, Chaim; Heuer, Herbertus; Merkely, Bela; Baracioli, Luciano et al. (March 2012). “Safety and efficacy of prasugrel compared with clopidogrel in different regions of the world”. International Journal of Cardiology155 (3): 424–429. doi:10.1016/j.ijcard.2010.10.040. ISSN0167-5273. PMID21093072.
Wiviott, Stephen D.; Braunwald, Eugene; McCabe, Carolyn H.; Montalescot, Gilles; Ruzyllo, Witold; Gottlieb, Shmuel; Neumann, Franz-Joseph; Ardissino, Diego et al. (2007-11-15). “Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes” (英語). New England Journal of Medicine357 (20): 2001–2015. doi:10.1056/NEJMoa0706482. ISSN0028-4793. PMID17982182.
“A case of resistance to clopidogrel and prasugrel after percutaneous coronary angioplasty”. Journal of Thrombosis and Thrombolysis31 (2): 233–4. (February 2011). doi:10.1007/s11239-010-0533-x. PMID21088983.
“Interactions of two major metabolites of prasugrel, a thienopyridine antiplatelet agent, with the cytochromes P450”. Drug Metabolism and Disposition34 (4): 600–7. (April 2006). doi:10.1124/dmd.105.007989. PMID16415119.
“Arylacetamide Deacetylase is Responsible for Activation of Prasugrel in Human and Dog”. Drug Metabolism and Disposition44 (3): 409–16. (March 2016). doi:10.1124/dmd.115.068221. PMID26718653.
Wiviott, Stephen D.; Braunwald, Eugene; McCabe, Carolyn H.; Montalescot, Gilles; Ruzyllo, Witold; Gottlieb, Shmuel; Neumann, Franz-Joseph; Ardissino, Diego et al. (15 November 2007). “Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes”. New England Journal of Medicine357 (20): 2001–2015. doi:10.1056/NEJMoa0706482. PMID17982182.
Wiviott, Stephen D.; Braunwald, Eugene; McCabe, Carolyn H.; Montalescot, Gilles; Ruzyllo, Witold; Gottlieb, Shmuel; Neumann, Franz-Joseph; Ardissino, Diego et al. (15 November 2007). “Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes”. New England Journal of Medicine357 (20): 2001–2015. doi:10.1056/NEJMoa0706482. PMID17982182.
Chew, Derek P; Scott, Ian A; Cullen, Louise; French, John K; Briffa, Tom G; Tideman, Philip A; Woodruffe, Stephen; Kerr, Alistair et al. (August 2016). “National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand: Australian clinical guidelines for the management of acute coronary syndromes 2016”. Medical Journal of Australia205 (3): 128–133. doi:10.5694/mja16.00368. PMID27465769.
“Current oral antiplatelets: focus update on prasugrel”. Journal of the American Board of Family Medicine25 (3): 343–9. (2012). doi:10.3122/jabfm.2012.03.100270. PMID22570398.
“Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials”. Lancet374 (9694): 989–997. (September 2009). doi:10.1016/S0140-6736(09)61525-7. PMID19726078.
Ruff, Christian T.; Giugliano, Robert P.; Antman, Elliott M.; Murphy, Sabina A.; Lotan, Chaim; Heuer, Herbertus; Merkely, Bela; Baracioli, Luciano et al. (March 2012). “Safety and efficacy of prasugrel compared with clopidogrel in different regions of the world”. International Journal of Cardiology155 (3): 424–429. doi:10.1016/j.ijcard.2010.10.040. ISSN0167-5273. PMID21093072.
Wiviott, Stephen D.; Braunwald, Eugene; McCabe, Carolyn H.; Montalescot, Gilles; Ruzyllo, Witold; Gottlieb, Shmuel; Neumann, Franz-Joseph; Ardissino, Diego et al. (2007-11-15). “Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes” (英語). New England Journal of Medicine357 (20): 2001–2015. doi:10.1056/NEJMoa0706482. ISSN0028-4793. PMID17982182.
“A case of resistance to clopidogrel and prasugrel after percutaneous coronary angioplasty”. Journal of Thrombosis and Thrombolysis31 (2): 233–4. (February 2011). doi:10.1007/s11239-010-0533-x. PMID21088983.
“Interactions of two major metabolites of prasugrel, a thienopyridine antiplatelet agent, with the cytochromes P450”. Drug Metabolism and Disposition34 (4): 600–7. (April 2006). doi:10.1124/dmd.105.007989. PMID16415119.
“Arylacetamide Deacetylase is Responsible for Activation of Prasugrel in Human and Dog”. Drug Metabolism and Disposition44 (3): 409–16. (March 2016). doi:10.1124/dmd.115.068221. PMID26718653.
Ruff, Christian T.; Giugliano, Robert P.; Antman, Elliott M.; Murphy, Sabina A.; Lotan, Chaim; Heuer, Herbertus; Merkely, Bela; Baracioli, Luciano et al. (March 2012). “Safety and efficacy of prasugrel compared with clopidogrel in different regions of the world”. International Journal of Cardiology155 (3): 424–429. doi:10.1016/j.ijcard.2010.10.040. ISSN0167-5273. PMID21093072.
Wiviott, Stephen D.; Braunwald, Eugene; McCabe, Carolyn H.; Montalescot, Gilles; Ruzyllo, Witold; Gottlieb, Shmuel; Neumann, Franz-Joseph; Ardissino, Diego et al. (2007-11-15). “Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes” (英語). New England Journal of Medicine357 (20): 2001–2015. doi:10.1056/NEJMoa0706482. ISSN0028-4793. PMID17982182.